| Detected | Trial | Change |
|---|---|---|
| 2026-07-17 | NCT05882877 A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult… |
Trial terminated |
| 2026-07-17 | NCT05882877 A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult… |
critical why stopped: null → "Sponsor Decision" |
| 2026-07-17 | NCT07213674 A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With… |
Trial sites expanded: 136 -> 140 locations |
| 2026-07-17 | NCT07313761 A Trial to Compare the Extent to Which Maridebart Cafraglutide (AMG 133) is Made… |
Trial completed |
| 2026-07-17 | NCT05920356 A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum… |
Trial sites expanded: 383 -> 401 locations |
| 2026-07-11 | NCT07037433 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in… |
Trial sites expanded: 774 -> 781 locations |
| 2026-07-11 | NCT06401044 A Study of AMG 732 in Healthy Participants and Participants With Thyroid Eye Disease |
Trial sites expanded: 40 -> 44 locations |
| 2026-07-10 | NCT06502977 Study Evaluating Tarlatamab in Chinese Participants With Advanced Small Cell Lung Cancer… |
date change Completion pushed: 2027-01-08 -> 2027-09-10 |
| 2026-07-08 | NCT06248619 A Trial to Investigate Teprotumumab Subcutaneous Administration Compared With Placebo in… |
date change Completion pushed: 2026-09-02 -> 2026-11-13 |
| 2026-07-07 | NCT07614776 A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA®… |
Trial sites expanded: 20 -> 27 locations |
| 2026-07-03 | NCT07575399 Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor… |
Trial sites expanded: 40 -> 43 locations |
| 2026-07-03 | NCT07037459 Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection… |
Trial sites expanded: 605 -> 628 locations |
| 2026-07-03 | NCT06376045 A Phase 2, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe Asthma |
Trial completed |
| 2026-07-02 | NCT07523711 Effect of Maridebart Cafraglutide on How Oral Contraceptives Are Absorbed and Processed… |
date change Primary completion pushed: 2026-10-07 -> 2026-11-18 |
| 2026-07-02 | NCT07523711 Effect of Maridebart Cafraglutide on How Oral Contraceptives Are Absorbed and Processed… |
date change Completion pushed: 2026-10-07 -> 2026-11-18 |
| 2026-07-02 | NCT07545226 Comparing the Extent to Which Two Evolocumab Drug Products Are Made Available in the Body… |
Recruitment opened |
| 2026-07-02 | NCT07545226 Comparing the Extent to Which Two Evolocumab Drug Products Are Made Available in the Body… |
Trial sites expanded: 0 -> 5 locations |
| 2026-07-01 | NCT04994717 Study Comparing Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard… |
date change Completion pushed: 2031-05-12 -> 2031-06-30 |
| 2026-07-01 | NCT03600883 A Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of Sotorasib… |
Trial completed |
| 2026-06-27 | NCT06598306 Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer… |
date change Primary completion pushed: 2027-03-03 -> 2027-04-24 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-07-13 | NCT07700238 A Study of Romiplostim Plus Predniso(lo)ne vs. Predniso(lo)ne Alone for the Treatment of… | Phase 3 | Not Yet Recruiting |
| 2026-07-06 | NCT07684144 Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of… | Phase 3 | Not Yet Recruiting |
| 2026-07-06 | NCT07684235 Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of… | Phase 3 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06072482 | A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis | Antineutrophil Cytoplasmic Antibody-associated Vasculitis | Recruiting |
| NCT06332014 | Evaluation of Efficacy and Safety of Prolia in Subjects of Male Osteoporosis in Mainland… | Osteoporosis | Active, Not Recruiting |
| NCT06588153 | A Study for the Evaluation of Efficacy and Safety of Prolia® in Participants With… | Glucocorticoid-induced Osteoporosis | Active, Not Recruiting |
| Phase 3 | |||
| NCT03633708 | A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and… | Secondary Hyperparathyroidism | Recruiting |
| NCT03969329 | A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving… | Secondary Hyperparathyroidism | Recruiting |
| NCT07293260 | Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary… | Cardiovascular Disease | Recruiting |
| NCT04804553 | Apremilast Pediatric Study in Children With Active Juvenile Psoriatic Arthritis | Active Juvenile Psoriatic Arthritis | Recruiting |
| NCT06747949 | A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) | Sjögren's Syndrome | Recruiting |
| NCT07225686 | Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea… | Obesity | Recruiting |
| NCT07226765 | Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea… | Obstructive Sleep Apnea | Recruiting |
| NCT06321601 | Study to Evaluate Avacopan in Combination With a Rituximab or Cyclophosphamide-containing… | Vasculitis | Recruiting |
| NCT07366086 | Pediatric Safety Follow-up Study of Prior Treatment With Romosozumab for Osteogenesis… | Osteogenesis Imperfecta | Recruiting |
| NCT07037459 | Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection… | Heart Failure With Preserved Ejection Fraction | Recruiting |
| NCT07575399 | Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor… | Obesity or Overweight | Recruiting |
| NCT07037433 | Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in… | Atherosclerotic Cardiovascular Disease | Recruiting |
| NCT07136012 | OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a)… | Cardiovascular Disease | Recruiting |
| NCT07388498 | A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and… | Uncontrolled Gout | Recruiting |
| NCT07614776 | A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA®… | Neovascular Age-related Macular Degeneration | Recruiting |
| NCT05920356 | A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum… | Non-Small Cell Lung Cancer (NSCLC) | Recruiting |
| NCT06252649 | Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without… | Metastatic Colorectal Cancer | Recruiting |
| NCT07005128 | A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab… | Small-cell Lung Cancer | Recruiting |
| NCT07213674 | A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With… | Metastatic Castration-resistant Prostate Cancer | Recruiting |
| NCT06858878 | Efficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes… | Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight | Active, Not Recruiting |
| NCT05740566 | Study Comparing Tarlatamab With Standard of Care Chemotherapy in Relapsed Small Cell Lung… | Small Cell Lung Cancer (SCLC) | Active, Not Recruiting |
| NCT06245408 | A Safety and Efficacy Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)… | Sjögren's Syndrome (SS) | Active, Not Recruiting |